The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer

Immune checkpoint inhibitors (ICI) have revolutionized cancer treatment and can result in complete remissions even at advanced stages of the disease. However, only a small fraction of patients respond to the treatment. To better understand which factors drive clinical benefit, we have generated whol...

Descripción completa

Detalles Bibliográficos
Autores principales: Boll, Lilian Marie, Perera-Bel, Júlia, Rodriguez-Vida, Alejo, Arpí, Oriol, Rovira, Ana, Juanpere, Núria, Vázquez Montes de Oca, Sergio, Hernández-Llodrà, Silvia, Lloreta, Josep, Albà, M. Mar, Bellmunt, Joaquim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504302/
https://www.ncbi.nlm.nih.gov/pubmed/37714872
http://dx.doi.org/10.1038/s41598-023-42495-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504302/
https://www.ncbi.nlm.nih.gov/pubmed/37714872
http://dx.doi.org/10.1038/s41598-023-42495-2

Ejemplares similares